1027 related articles for article (PubMed ID: 19909746)
1. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
2. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
3. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.
Pertuit D; Moulari B; Betz T; Nadaradjane A; Neumann D; Ismaïli L; Refouvelet B; Pellequer Y; Lamprecht A
J Control Release; 2007 Nov; 123(3):211-8. PubMed ID: 17889397
[TBL] [Abstract][Full Text] [Related]
4. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
Rabišková M; Bautzová T; Gajdziok J; Dvořáčková K; Lamprecht A; Pellequer Y; Spilková J
Int J Pharm; 2012 Jan; 422(1-2):151-9. PubMed ID: 22079717
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal delivery of anti-inflammatory nanoparticles.
Laroui H; Sitaraman SV; Merlin D
Methods Enzymol; 2012; 509():101-25. PubMed ID: 22568903
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D
Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126
[TBL] [Abstract][Full Text] [Related]
7. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
8. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
9. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.
Dalmasso G; Charrier-Hisamuddin L; Nguyen HT; Yan Y; Sitaraman S; Merlin D
Gastroenterology; 2008 Jan; 134(1):166-78. PubMed ID: 18061177
[TBL] [Abstract][Full Text] [Related]
10. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
11. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.
Kannengiesser K; Maaser C; Heidemann J; Luegering A; Ross M; Brzoska T; Bohm M; Luger TA; Domschke W; Kucharzik T
Inflamm Bowel Dis; 2008 Mar; 14(3):324-31. PubMed ID: 18092346
[TBL] [Abstract][Full Text] [Related]
13. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
[TBL] [Abstract][Full Text] [Related]
14. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles.
Ling K; Wu H; Neish AS; Champion JA
J Control Release; 2019 Feb; 295():174-186. PubMed ID: 30557649
[TBL] [Abstract][Full Text] [Related]
15. Attenuation by dietary taurine of dextran sulfate sodium-induced colitis in mice and of THP-1-induced damage to intestinal Caco-2 cell monolayers.
Zhao Z; Satsu H; Fujisawa M; Hori M; Ishimoto Y; Totsuka M; Nambu A; Kakuta S; Ozaki H; Shimizu M
Amino Acids; 2008 Jun; 35(1):217-24. PubMed ID: 17619120
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment.
Jiang GL; Im WB; Donde Y; Wheeler LA
J Pharmacol Exp Ther; 2010 Dec; 335(3):546-52. PubMed ID: 20833794
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.
Coco R; Plapied L; Pourcelle V; Jérôme C; Brayden DJ; Schneider YJ; Préat V
Int J Pharm; 2013 Jan; 440(1):3-12. PubMed ID: 22820482
[TBL] [Abstract][Full Text] [Related]
18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
19. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
[TBL] [Abstract][Full Text] [Related]
20. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
